Fracture Risk Assessed Among Users of SGLT-2 Inhibitors vs Other Antidiabetic Agents By Diana Ernst, RPh Publish Date October 27, 2021
Zolgensma Labeling Updated With Additional Safety Information By Brian Park, PharmD Publish Date October 27, 2021
Response to Pegloticase Therapy Improved With Concomitant Methotrexate By Brian Park, PharmD Publish Date October 27, 2021
FDA Panel Votes in Favor of Pfizer-BioNTech COVID-19 Vaccine for 5 to 11 Year-Olds By Diana Ernst, RPh Publish Date October 26, 2021
Nemvaleukin Alfa Plus Pembrolizumab Fast Tracked for Platinum-Resistant Ovarian Cancer By Brian Park, PharmD Publish Date October 26, 2021
Alvelestat Designated Orphan Drug for Alpha-1 Antitrypsin Deficiency By Brian Park, PharmD Publish Date October 26, 2021
RCT Data Needed on Phosphate-Lowering Agents and NDD-CKD Outcomes By Natasha Persaud Publish Date October 26, 2021
Strong Antibody Response With Moderna COVID-19 Vaccine in Pediatric Trial By Brian Park, PharmD Publish Date October 25, 2021
Comparable Efficacy Seen With Doravirine/Islatravir vs 3-Drug HIV Regimens By Brian Park, PharmD Publish Date October 25, 2021
Xipere for Suprachoroidal Use Approved for Macular Edema Associated With Uveitis By Brian Park, PharmD Publish Date October 25, 2021
Susvimo Approved for Wet Age-Related Macular Degeneration By Brian Park, PharmD Publish Date October 25, 2021
